Principal Investigator
Marco Pravetoni is the Rick L. Seaver Endowed Professor of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, and Director of a Center for Medication Development for Substance Use Disorders and Overdose. Prior to joining the University of Washington, Marco was a Tenured Associate Professor of Pharmacology at the University of Minnesota Medical School in Minneapolis, MN. He earned a PhD in Pharmacology from the University of Minnesota in 2008. His NIH-funded research program focuses on the pre-clinical and clinical development of vaccines, monoclonal antibodies, and small molecules to treat opioid use disorders and reduce fatal overdoses. Other interests include biologics targeting chemical and biological threats.